GKOSMID

Glaukos Corporation

HealthcareMedical - Devices
$130.68
$0.03(+2.57%)
52W$73.16
$148.11
Updated Jun 22, 02:00 AM
RSI54
RS Rating79/99
Beta1.02
Volatility52%
F-Score3/9
Mkt Cap$7.6B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Glaukos Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 79), indicating performance broadly in line with the market. Earnings contraction of 6% provides fundamental context to the price action. Investors should exercise caution due to high volatility (52% annualized), which requires wider risk management.

Relative Strength
79
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.02
vs S&P 500
MARKET
52W Position
77%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$125.91
50 SMA > 100 SMA$118.82
100 SMA > 150 SMA$115.68
150 SMA > 200 SMA$107.80

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$120.29+8.64%ABOVE
50 SMA$125.91+3.79%ABOVE
100 SMA$118.82+9.98%ABOVE
150 SMA$115.68+12.97%ABOVE
200 SMA$107.80+21.22%ABOVE

Price Performance

1D+2.6%
1W+5.2%
1M-8.1%
3M+26.6%
6M+15.4%
YTD+18.0%
1Y+27.7%
3Y+25.2%
52-Week Trading Range77% from low
$130.68
52W Low$73.16
52W High$148.11

Technical Indicators

RSI (14)NEUTRAL
53.6
305070
Setup ScoreCOOL
4/10
Base depth: 37.2%

Risk Profile

Beta
1.02
52W Vol
52%
ATR
$6.47
Max DD (1Y)
-30%

Volume Analysis

Today
867.3K
50D Avg
880.0K
Vol Ratio
0.99x
Liquidity
LIQUID

Earnings Momentum

Q2'25+68%
$-0.34
Q3'25+28%
$-0.28
Q4'25-287%
$-2.32
Q1'26-6%
$-0.34
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+21.61%
5 Years:+17.67%
3 Years:+21.51%
TTM:+36.30%

Compounded Profit Growth

10 Years:-4.41%
5 Years:
3 Years:
TTM:-38.40%

Stock Price CAGR

10 Years:+16.04%
5 Years:+9.80%
3 Years:+25.20%
1 Year:+27.69%

Return on Equity

10Y Avg:-12.1%
5Y Avg:-20.6%
3Y Avg:-25.8%
Last Year:-26.5%

Key Metrics

Market Cap$7.6B
Gross Margin77.5%
Net Margin-37.0%
Piotroski F-Score3/9

Frequently Asked Questions

Is GKOS in an uptrend right now?

GKOS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, GKOS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is GKOS overbought or oversold?

GKOS's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.

Is GKOS outperforming the market?

GKOS has a Relative Strength (RS) Rating of 79 out of 99. GKOS is performing about average compared to the market.

Where is GKOS in its 52-week range?

GKOS is trading at $130.68, which is 88% of its 52-week high ($148.11) and 77% above its 52-week low ($73.16).

How volatile is GKOS?

GKOS has a Beta of 1.02 and 52-week volatility of 52%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.